Report Categories Report Categories

Report Categories

industry Category

All

Total: 7 records, 1 pages

Global Pseudouridine Supply, Demand and Key Producers, 2024-2030

date 22 Jul 2024

date Pharma & Healthcare

new_biaoQian Pseudouridine

Pseudouridine was discovered in 1951. As the first modified nucleoside discovered in RNA, pseudouridine is considered to be the "fifth nucleoside" in RNA. Pseudouridine is also an isomer of uridine and the most abundant modified nucleoside in non-coding RNA. Pseudouridine is widely present in tRNA, mRNA, snRNA, and snoRNA, and is widely used in nucleic acid drugs.

USD4480.00

Add To Cart

Add To Cart

Global Pseudouridine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 22 Jul 2024

date Pharma & Healthcare

new_biaoQian Pseudouridine

Pseudouridine was discovered in 1951. As the first modified nucleoside discovered in RNA, pseudouridine is considered to be the "fifth nucleoside" in RNA. Pseudouridine is also an isomer of uridine and the most abundant modified nucleoside in non-coding RNA. Pseudouridine is widely present in tRNA, mRNA, snRNA, and snoRNA, and is widely used in nucleic acid drugs.

USD3480.00

Add To Cart

Add To Cart

Global RNA Modified Pseudouridine Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 26 Aug 2024

date Medical Care

new_biaoQian RNA Modified Pseudouridine

RNA modified pseudouridine is a common form of RNA base modification. It is slightly different in structure from conventional uridine (Uridine, U), but plays an important role in biological function.

USD3480.00

Add To Cart

Add To Cart

Global RNA Modified Pseudouridine Supply, Demand and Key Producers, 2024-2030

date 26 Aug 2024

date Medical Care

new_biaoQian RNA Modified Pseudouridine

RNA modified pseudouridine is a common form of RNA base modification. It is slightly different in structure from conventional uridine (Uridine, U), but plays an important role in biological function.

USD4480.00

Add To Cart

Add To Cart

Global Pseudouridine Triphosphate Tetrasodium Salt Solution Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 23 Sep 2024

date Pharma & Healthcare

new_biaoQian Pseudouridine Triphosphate Tetrasodium Salt Solution

Pseudouridine triphosphate tetrasodium salt solution is a phosphorylated derivative of pseudouridine (Pseudouridine), which exists in the form of tetrasodium salt. Pseudouridine is a modified nucleoside and the "fifth nucleoside" in RNA. It was discovered in 1951. The pseudouridine triphosphate formed after phosphorylation combines with four sodium ions to form pseudouridine triphosphate tetrasodium salt. The molecular formula of this compound may vary depending on the specific product, but generally contains elements such as C, H, N, O, P, and Na, and its molecular weight is also relatively large. Pseudouridine triphosphate tetrasodium salt has important biological functions in organisms. As a modified component of RNA, it is widely present in a variety of RNA molecules such as tRNA, mRNA, snRNA, and snoRNA, and has a profound effect on the structure and function of RNA. Studies have shown that replacing uridine with pseudouridine can significantly reduce the immunogenicity of in vitro transcribed mRNA and improve the stability and expression intensity of mRNA. This characteristic makes pseudouridine triphosphate tetrasodium salt have broad application prospects in biotechnology fields such as mRNA vaccines and gene therapy.

USD3480.00

Add To Cart

Add To Cart

Global Pseudouridine Triphosphate Tetrasodium Salt Solution Supply, Demand and Key Producers, 2024-2030

date 23 Sep 2024

date Pharma & Healthcare

new_biaoQian Pseudouridine Triphosphate Tetrasodium Salt Solution

Pseudouridine triphosphate tetrasodium salt solution is a phosphorylated derivative of pseudouridine (Pseudouridine), which exists in the form of tetrasodium salt. Pseudouridine is a modified nucleoside and the "fifth nucleoside" in RNA. It was discovered in 1951. The pseudouridine triphosphate formed after phosphorylation combines with four sodium ions to form pseudouridine triphosphate tetrasodium salt. The molecular formula of this compound may vary depending on the specific product, but generally contains elements such as C, H, N, O, P, and Na, and its molecular weight is also relatively large. Pseudouridine triphosphate tetrasodium salt has important biological functions in organisms. As a modified component of RNA, it is widely present in a variety of RNA molecules such as tRNA, mRNA, snRNA, and snoRNA, and has a profound effect on the structure and function of RNA. Studies have shown that replacing uridine with pseudouridine can significantly reduce the immunogenicity of in vitro transcribed mRNA and improve the stability and expression intensity of mRNA. This characteristic makes pseudouridine triphosphate tetrasodium salt have broad application prospects in biotechnology fields such as mRNA vaccines and gene therapy.

USD4480.00

Add To Cart

Add To Cart

Global Pseudouridine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

new_biaoQian Pseudouridine

Pseudouridine, an isomer of uridine (U), is used as a tumor marker to guide the diagnosis, monitoring and efficacy assessment of malignancies such as lung, breast and liver cancers. Although normal mRNA present in vivo has uridine as one of the four nucleic acid compounds in the sequence, mRNA developed as a therapeutic agent or vaccine is made using a modified nucleic acid (pseudouridine) instead of uridine (and other derivatives). Pseudouridine was originally present in the body as a component, such as tRNA (transfer RNA), which is a type of RNA.

USD3480.00

Add To Cart

Add To Cart

industry 22 Jul 2024

industry Pharma & Healthcare

new_biaoQian Pseudouridine

Pseudouridine was discovered in 1951. As the first modified nucleoside discovered in RNA, pseudouridine is considered to be the "fifth nucleoside" in RNA. Pseudouridine is also an isomer of uridine and the most abundant modified nucleoside in non-coding RNA. Pseudouridine is widely present in tRNA, mRNA, snRNA, and snoRNA, and is widely used in nucleic acid drugs.

USD4480.00

addToCart

Add To Cart

industry 22 Jul 2024

industry Pharma & Healthcare

new_biaoQian Pseudouridine

Pseudouridine was discovered in 1951. As the first modified nucleoside discovered in RNA, pseudouridine is considered to be the "fifth nucleoside" in RNA. Pseudouridine is also an isomer of uridine and the most abundant modified nucleoside in non-coding RNA. Pseudouridine is widely present in tRNA, mRNA, snRNA, and snoRNA, and is widely used in nucleic acid drugs.

USD3480.00

addToCart

Add To Cart

industry 26 Aug 2024

industry Medical Care

new_biaoQian RNA Modified Pseudouridine

RNA modified pseudouridine is a common form of RNA base modification. It is slightly different in structure from conventional uridine (Uridine, U), but plays an important role in biological function.

USD3480.00

addToCart

Add To Cart

industry 26 Aug 2024

industry Medical Care

new_biaoQian RNA Modified Pseudouridine

RNA modified pseudouridine is a common form of RNA base modification. It is slightly different in structure from conventional uridine (Uridine, U), but plays an important role in biological function.

USD4480.00

addToCart

Add To Cart

Pseudouridine triphosphate tetrasodium salt solution is a phosphorylated derivative of pseudouridine (Pseudouridine), which exists in the form of tetrasodium salt. Pseudouridine is a modified nucleoside and the "fifth nucleoside" in RNA. It was discovered in 1951. The pseudouridine triphosphate formed after phosphorylation combines with four sodium ions to form pseudouridine triphosphate tetrasodium salt. The molecular formula of this compound may vary depending on the specific product, but generally contains elements such as C, H, N, O, P, and Na, and its molecular weight is also relatively large. Pseudouridine triphosphate tetrasodium salt has important biological functions in organisms. As a modified component of RNA, it is widely present in a variety of RNA molecules such as tRNA, mRNA, snRNA, and snoRNA, and has a profound effect on the structure and function of RNA. Studies have shown that replacing uridine with pseudouridine can significantly reduce the immunogenicity of in vitro transcribed mRNA and improve the stability and expression intensity of mRNA. This characteristic makes pseudouridine triphosphate tetrasodium salt have broad application prospects in biotechnology fields such as mRNA vaccines and gene therapy.

USD3480.00

addToCart

Add To Cart

Pseudouridine triphosphate tetrasodium salt solution is a phosphorylated derivative of pseudouridine (Pseudouridine), which exists in the form of tetrasodium salt. Pseudouridine is a modified nucleoside and the "fifth nucleoside" in RNA. It was discovered in 1951. The pseudouridine triphosphate formed after phosphorylation combines with four sodium ions to form pseudouridine triphosphate tetrasodium salt. The molecular formula of this compound may vary depending on the specific product, but generally contains elements such as C, H, N, O, P, and Na, and its molecular weight is also relatively large. Pseudouridine triphosphate tetrasodium salt has important biological functions in organisms. As a modified component of RNA, it is widely present in a variety of RNA molecules such as tRNA, mRNA, snRNA, and snoRNA, and has a profound effect on the structure and function of RNA. Studies have shown that replacing uridine with pseudouridine can significantly reduce the immunogenicity of in vitro transcribed mRNA and improve the stability and expression intensity of mRNA. This characteristic makes pseudouridine triphosphate tetrasodium salt have broad application prospects in biotechnology fields such as mRNA vaccines and gene therapy.

USD4480.00

addToCart

Add To Cart

industry 18 Mar 2023

industry Pharma & Healthcare

new_biaoQian Pseudouridine

Pseudouridine, an isomer of uridine (U), is used as a tumor marker to guide the diagnosis, monitoring and efficacy assessment of malignancies such as lung, breast and liver cancers. Although normal mRNA present in vivo has uridine as one of the four nucleic acid compounds in the sequence, mRNA developed as a therapeutic agent or vaccine is made using a modified nucleic acid (pseudouridine) instead of uridine (and other derivatives). Pseudouridine was originally present in the body as a component, such as tRNA (transfer RNA), which is a type of RNA.

USD3480.00

addToCart

Add To Cart